MAP3K Family Review and Correlations with Patient Survival Outcomes in Various Cancer Types

Khoa Nguyen1, Minh N Tran1, Andrew Rivera1

  • 1Department of Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA.

Insights

Mitogen-activated protein kinase (MAPK) pathways are crucial for cell function, and their disruption can cause cancer. This review examines MAP3K family members and their link to cancer patient survival, highlighting their importance in signaling.

Area of Science:

  • Cellular signaling
  • Molecular biology
  • Oncology

Background:

  • Mitogen-activated protein kinase (MAPK) pathways are fundamental to cellular signaling and biological processes.
  • Aberrations in MAPK signaling are implicated in various diseases, notably cancer development.
  • The MAP3K family, a key component of MAPK pathways, plays critical roles in cellular regulation.

Purpose of the Study:

  • To review the members of the MAP3K family.
  • To correlate MAP3K mRNA expression levels with patient survival outcomes across different cancer types.
  • To emphasize the significance of studying the MAP3K family in the context of cancer progression and MAPK signaling.

Main Methods:

  • Literature review of MAP3K family members.
  • Analysis of publicly available mRNA expression data.
  • Correlation analysis between MAP3K mRNA levels and patient survival data in various cancers.

Main Results:

  • Identification of key MAP3K family members involved in cancer.
  • Demonstration of correlations between specific MAP3K mRNA expression levels and patient survival rates.
  • Highlighting of differential expression patterns of MAP3K genes in distinct cancer types.

Conclusions:

  • The MAP3K family is integral to MAPK signaling and cancer progression.
  • MAP3K mRNA expression levels serve as potential prognostic biomarkers in cancer.
  • Further research into the MAP3K family is warranted due to their understudied nature and therapeutic potential.

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
463
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.2K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
284